IRCT20210307050611N1招募中3 期
Mesenchymal stem cell injection in patients with knee osteoarthritis compared to a randomized controlled trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •Knee Osteoarthritis Based on American College of Rheumatology Criteria in Grades 1, 2, and 3: Lowrence - Kellergan
- •Knee pain for at least six months
- •Proper liver function (Bilirubin = 2.0 ?/?, AST/ALT = 100 IU/L)
- •Proper renal function (Creatinine = 2.0 ?/?)
排除标准
- •Any acute or chronic infection
- •Pregnancy or decision to become pregnant
- •Any intra-articular injection during the last three months
- •Inflammatory joint disease or secondary osteoarthritis
- •History of knee surgery
- •Severe underlying disease such as uncontrolled diabetes, taking anticoagulants
- •Daily use of opioid and non-opioid analgesics
研究者
相似试验
进行中（未招募）
不适用
Therapeutic effect of mesenchymal cells in patients suffering from a disease characterized by a severe inflammation and/or in whom the immune system attacks their own tissues.MedDRA version: 14.0Level: LLTClassification code 10011402Term: Crohn's disease (colon)System Organ Class: 10017947 - Gastrointestinal disordersMedDRA version: 14.0Level: HLGTClassification code 10003816Term: Autoimmune disordersSystem Organ Class: 10021428 - Immune system disordersMedDRA version: 14.0Level: PTClassification code 10064147Term: Gastrointestinal inflammationSystem Organ Class: 10017947 - Gastrointestinal disordersMedDRA version: 14.0Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersCrohn's diseaseEUCTR2011-005966-39-BECHU-ULg20
进行中（未招募）
1 期
Mesenchymal stem cell therapy in patients with severe myocardial ischemia - Stem celle therapy in ischemic heart diseaseChronic coronary artery diseaseEUCTR2005-002657-45-DKCardiovascular laboratory 2014, Rigshospitalet40
进行中（未招募）
1 期
Infusion of mesenchymal stem cells as treatment for steroid resistant grade II to IV acute GVHD or poor graft function: a multicenter phase II studyEUCTR2007-004310-14-BECHU-ULG120
撤回
2 期
Infusion of mesenchymal stem cells as treatment for steroid resistant grade II to IV acute GVHD or poor graft function: a multicenter phase II studymesenchymale stamcellen bij acute GvHD of onvoldoende functionerende greffeacute GvHD1002432410018865rejectionNL-OMON31471Academisch Ziekenhuis Maastricht10
招募中
2 期
Cotransplantation of mesenchymal stem cells with nonmyeloablative haploidentical peripheral blood stem cells without T cells deleted for high-risk acute leukemia: to reduce the severity of graft versus host disease and relapseHigh-risk acute leukemia patientsCancer - Leukaemia - Acute leukaemiaACTRN12608000129381Huisheng Ai40